McKesson Corporation


in
McKesson Corporation signed a definitive agreement to acquire McQueary Bros Drug Company for approximately $190 million on April 8, 2008. The deal is subject to subject to customary closing conditions and regulatory approvals. McQueary Brothers will be integrated into McKesson's U.S. Pharmaceutical business, which is reported in the McKesson Distribution Solutions segment. The acquisition is expected to close in the second quarter of 2008. The acquisition will have no significant impact on McKesson’s financial year 2009 earnings and will be modestly accretive to financial year 2010 earnings per fully diluted share.